Home
/
BALCHEM CORP
/
Financials
/
Quarterly
BALCHEM CORP — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that BALCHEM CORP filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2017
Sep 30, 2017
$150.72M
Nov 7, 2017
Q2
2017
Jun 30, 2017
$147.08M
Aug 4, 2017
Q1
2017
Mar 31, 2017
$137.73M
May 9, 2017
Q3
2017
Sep 30, 2016
$138.51M
Nov 7, 2017
Q2
2017
Jun 30, 2016
$138.79M
Aug 4, 2017
Q1
2017
Mar 31, 2016
$135.14M
May 9, 2017
Q3
2016
Sep 30, 2015
$140.13M
Nov 4, 2016
Q2
2016
Jun 30, 2015
$134.77M
Aug 5, 2016
Q1
2016
Mar 31, 2015
$144.86M
May 10, 2016
Q3
2015
Sep 30, 2014
$160.49M
Nov 4, 2015
Q2
2015
Jun 30, 2014
$132.23M
Aug 5, 2015
Q1
2015
Mar 31, 2014
$86.00M
May 7, 2015
Q3
2014
Sep 30, 2013
$87.59M
Nov 10, 2014
Q2
2014
Jun 30, 2013
$83.30M
Aug 8, 2014
Q1
2014
Mar 31, 2013
$84.65M
May 5, 2014
Q3
2013
Sep 30, 2012
$75.12M
Nov 5, 2013
Q2
2013
Jun 30, 2012
$79.01M
Aug 2, 2013
Q1
2013
Mar 31, 2012
$76.20M
May 3, 2013
Q3
2012
Sep 30, 2011
$74.44M
Nov 2, 2012
Q2
2012
Jun 30, 2011
$74.69M
Aug 3, 2012
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$267.56M
Oct 21, 2025
Q2
2025
Jun 30, 2025
$255.47M
Jul 31, 2025
Q1
2025
Mar 31, 2025
$250.52M
Apr 24, 2025
Q3
2025
Sep 30, 2024
$239.94M
Oct 21, 2025
Q2
2025
Jun 30, 2024
$234.08M
Jul 31, 2025
Q1
2025
Mar 31, 2024
$239.66M
Apr 24, 2025
Q3
2024
Sep 30, 2023
$229.95M
Oct 25, 2024
Q2
2024
Jun 30, 2023
$231.25M
Jul 26, 2024
Q1
2024
Mar 31, 2023
$232.54M
May 3, 2024
Q3
2023
Sep 30, 2022
$244.27M
Oct 27, 2023
Q2
2023
Jun 30, 2022
$236.69M
Jul 28, 2023
Q1
2023
Mar 31, 2022
$228.87M
Apr 28, 2023
Q3
2022
Sep 30, 2021
$197.87M
Nov 4, 2022
Q2
2022
Jun 30, 2021
$202.37M
Jul 29, 2022
Q1
2022
Mar 31, 2021
$185.66M
Apr 29, 2022
Q3
2021
Sep 30, 2020
$175.14M
Oct 29, 2021
Q2
2021
Jun 30, 2020
$173.36M
Jul 30, 2021
Q1
2021
Mar 31, 2020
$174.44M
Apr 30, 2021
Q3
2020
Sep 30, 2019
$158.60M
Oct 28, 2020
Q2
2020
Jun 30, 2019
$161.55M
Jul 31, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$40.29M
Oct 21, 2025
Q3
2025
Jun 30, 2025
$38.28M
Oct 21, 2025
Q2
2025
Jun 30, 2025
$38.28M
Jul 31, 2025
Q1
2025
Mar 31, 2025
$37.05M
Apr 24, 2025
Q2
2025
Mar 31, 2025
$37.05M
Jul 31, 2025
Q3
2025
Mar 31, 2025
$37.05M
Oct 21, 2025
Q3
2025
Sep 30, 2024
$33.84M
Oct 21, 2025
Q2
2025
Jun 30, 2024
$32.07M
Jul 31, 2025
Q3
2025
Jun 30, 2024
$32.07M
Oct 21, 2025
Q3
2025
Mar 31, 2024
$28.99M
Oct 21, 2025
Q1
2025
Mar 31, 2024
$28.99M
Apr 24, 2025
Q2
2025
Mar 31, 2024
$28.99M
Jul 31, 2025
Q3
2024
Sep 30, 2023
$29.08M
Oct 25, 2024
Q3
2024
Jun 30, 2023
$30.11M
Oct 25, 2024
Q2
2024
Jun 30, 2023
$30.11M
Jul 26, 2024
Q2
2024
Mar 31, 2023
$22.71M
Jul 26, 2024
Q1
2024
Mar 31, 2023
$22.71M
May 3, 2024
Q3
2024
Mar 31, 2023
$22.71M
Oct 25, 2024
Q3
2023
Sep 30, 2022
$25.25M
Oct 27, 2023
Q2
2023
Jun 30, 2022
$29.78M
Jul 28, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$54.58M
Oct 21, 2025
Q2
2025
Jun 30, 2025
$51.44M
Jul 31, 2025
Q1
2025
Mar 31, 2025
$51.02M
Apr 24, 2025
Q3
2025
Sep 30, 2024
$47.99M
Oct 21, 2025
Q2
2025
Jun 30, 2024
$45.80M
Jul 31, 2025
Q1
2025
Mar 31, 2024
$41.68M
Apr 24, 2025
Q3
2024
Sep 30, 2023
$43.61M
Oct 25, 2024
Q2
2024
Jun 30, 2023
$42.84M
Jul 26, 2024
Q1
2024
Mar 31, 2023
$34.41M
May 3, 2024
Q3
2023
Sep 30, 2022
$33.63M
Oct 27, 2023
Q2
2023
Jun 30, 2022
$39.92M
Jul 28, 2023
Q1
2023
Mar 31, 2022
$38.34M
Apr 28, 2023
Q3
2022
Sep 30, 2021
$32.51M
Nov 4, 2022
Q2
2022
Jun 30, 2021
$30.59M
Jul 29, 2022
Q1
2022
Mar 31, 2021
$30.58M
Apr 29, 2022
Q3
2021
Sep 30, 2020
$29.03M
Oct 29, 2021
Q2
2021
Jun 30, 2020
$26.92M
Jul 30, 2021
Q1
2021
Mar 31, 2020
$26.28M
Apr 30, 2021
Q3
2020
Sep 30, 2019
$26.03M
Oct 28, 2020
Q2
2020
Jun 30, 2019
$26.40M
Jul 31, 2020